Top compounds associated with response to RTN1


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.27 4e-12
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 1e-10
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 6e-10
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.22 4e-09
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.23 5e-09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 2e-08
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.2 2e-08
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.21 3e-08
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.19 1e-07
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-07
Download CSV